Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. (CURA.TO) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cura.to · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Curaleaf Holdings, Inc. (CURA.TO) measures how much investors pay for each dollar of the company's trailing earnings. CURA.TO's current PE ratio of N/A is calculated by dividing its stock price of $16.21 by its TTM earnings per share of -$0.40.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2014 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Curaleaf Holdings, Inc.You CURA.TO | $3.8B | N/A | — | -$0.40 |
 Bausch Health Companies Inc. BHC.TO | $2.8B | 16.11x | -0.4% | $0.43 |
 Cresco Labs Inc. CL.CN | $439M | N/A | — | -$0.40 |
 Cronos Group Inc. CRON.TO | $1.4B | N/A | — | -$0.03 |
 Green Thumb Industries Inc. GTII.CN | $2.7B | 16.23x | +0.4% | $0.50 |
 Greenway Greenhouse Cannabis Corporation GWAY.CN | $21M | N/A | — | -$0.02 |
 HLS Therapeutics Inc. HLS.TO | $140M | N/A | — | -$0.40 |
Industry Average 2 peers with valid PE | — | 16.17x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.93 | — | |
2024-12-31 FY2024 | — | $-0.87 | — | |
2023-12-31 FY2023 | — | $-1.16 | — | |
2022-12-31 FY2022 | — | $-1.59 | — | |
2021-12-31 FY2021 | — | $-0.47 | — | |
2020-12-31 FY2020 | — | $-0.33 | — | |
2019-12-31 FY2019 | — | $-0.45 | — | |
2018-12-31 FY2018 | — | $-0.47 | — | |
2017-12-31 FY2017 | — | $-0.05 | — | |
2016-12-31 FY2016 | — | $-0.31 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Curaleaf Holdings, Inc. (CURA.TO) measures how much investors pay for each dollar of the company's trailing earnings. CURA.TO's current PE ratio of N/A is calculated by dividing its stock price of $16.21 by its TTM earnings per share of -$0.40.
Frequently asked questions
CURA.TO pe ratio · 6 questionsCURA.TO's current PE ratio is N/A as of 2026-06-08, based on a stock price of $16.21 and TTM EPS of -$0.40. Data sourced from Financial Modeling Prep via CURA.TO's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Curaleaf Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08